Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by stockbuphoonon Aug 17, 2021 3:21pm
65 Views
Post# 33718176

RE:these spammers here all day telling u to sell are

RE:these spammers here all day telling u to sell are

With all of your buying from $20 for that $50 easy call last year, you must be really loaded up at many different levels for a cost average of $10 or more if you bought every time you say you're buying which is pretty much every week. Did you get enough on June 4th when it popped to $7 or when it fell to $5 on June 7th or every drop of 25 cents? You are going to be the big winner when  they shut this thing down. Did you hear the conference call? They were hopeful that all conditions on that $72.5M were met by next Quarterly call in November... so they need a financing, you clown. And they have no lead institutional investor as the last two got screwed and they have no plan for clinical trials. 

Newcamo wrote: ......bu....bu.......buy.......buyi.......buying!!!!!!! market cap 70M$, cash at hand 140M$....news soon like operational update/analysts update! Stock is being held back while the big fish buys, but it will let go and this baby will ride...........

 

<< Previous
Bullboard Posts
Next >>